Top

Published in:

Open Access 01-12-2015 | Research

Insulin improves memory and reduces chronic neuroinflammation in the hippocampus of young but not aged brains

Authors: Linda Adzovic, Ashley E Lynn, Heather M D’Angelo, Alexis M Crockett, Roxanne M Kaercher, Sarah E Royer, Sarah C Hopp, Gary L Wenk

Published in: Journal of Neuroinflammation | Issue 1/2015

Abstract

The role of insulin in the brain is still not completely understood. In the periphery, insulin can decrease inflammation induced by lipopolysaccharide (LPS); however, whether insulin can reduce inflammation within the brain is unknown. Experiments administrating intranasal insulin to young and aged adults have shown that insulin improves memory. In our animal model of chronic neuroinflammation, we administered insulin and/or LPS directly into the brain via the fourth ventricle for 4 weeks in young rats; we then analyzed their spatial memory and neuroinflammatory response. Additionally, we administered insulin or artificial cerebral spinal fluid (aCSF), in the same manner, to aged rats and then analyzed their spatial memory and neuroinflammatory response. Response to chronic neuroinflammation in young rats was analyzed in the presence or absence of insulin supplementation. Here, we show for the first time that insulin infused (i.c.v.) to young rats significantly attenuated the effects of LPS by decreasing the expression of neuroinflammatory markers in the hippocampus and by improving performance in the Morris water pool task. In young rats, insulin infusion alone significantly improved their performance as compared to all other groups. Unexpectedly, in aged rats, the responsiveness to insulin was completely absent, that is, spatial memory was still impaired suggesting that an age-dependent insulin resistance may contribute to the cognitive impairment observed in neurodegenerative diseases. Our data suggest a novel therapeutic effect of insulin on neuroinflammation in the young but not the aged brain.

Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cooper NR, et al. Inflammation in Alzheimer’s disease. Neurobiol Aging. 2000;21:383–421.PubMedCentralCrossRefPubMed

Lynch AM, Lynch MA. The age-related increase in IL-1 type I receptor in rat hippocampus is coupled with an increase in caspase-3 activation. Eur J Neurosci. 2002;15:1779–88.CrossRefPubMed

Campuzano O, Castillo-Ruiz MM, Acarin L, Castellano B, Gonzalez B. Increased levels of proinflammatory cytokines in the aged rat brain attenuate injury-induced cytokine response after excitotoxic damage. J Neurosci Res. 2009;87:2484–97.CrossRefPubMed

Ye SM, Johnson RW. Increased interleukin-6 expression by microglia from brain of aged mice. J Neuroimmunol. 1999;9:139–48.CrossRef

Colton C, Wilcock DM. Assessing activation states in microglia. CNS Neurol Disord Drug Targets. 2010;9:174–91.CrossRefPubMed

Smith JA, Das A, Ray SK, Banik NL. Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res Bull. 2012;87:10–20.CrossRefPubMed

Wenk GL, Hauss-Wegrzyniak B. Animal models of chronic neuroinflammation as a model of Alzheimer’s disease. In: Bondy S, Campbell A, editors. Inflammatory events in neurodegeneration. Scottsdale, AZ: Prominent Press; 2001. p. 83–7.

Bilbo SD. Early-life infection is a vulnerability factor for aging-related glial alterations and cognitive decline. Neurobiol Learn Mem. 2010;94:57–64.PubMedCentralCrossRefPubMed

Eikelenboom P, van Exel E, Hoozemans JJ, Veerhuis R, Rozemuller AJ, van Gool WA. Neuroinflammation - an early event in both the history and pathogenesis of Alzheimer’s disease. Neurodegener Dis. 2010;7:38–41.CrossRefPubMed

10.

Heneka MT, Nadrigny F, Regen T, Martinez-Hernandez A, Dumitrescu-Ozimek L, Terwel D, et al. Locus ceruleus controls Alzheimer’s disease pathology by modulating microglial functions through norepinephrine. Proc Natl Acad Sci U S A. 2010;107:6058–63.PubMedCentralCrossRefPubMed

11.

Watson GS, Craft S. Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer’s disease. Eur J Pharmacol. 2004;490:97–113.CrossRefPubMed

12.

Arnold SE, Arvanitakis Z, Bakshi KP, Bennett DA, Fuino RL, Han LY. Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest. 2012;122:1316–38.PubMedCentralCrossRefPubMed

13.

Najem D, Bamji-Mirza M, Chang N, Liu QY, Zhang W. Insulin resistance, neuroinflammation, and Alzheimer’s disease. Rev Neurosci. 2014;25:509–25.CrossRefPubMed

14.

Jeschke MG, Klein D, Bolder U, Einspanier R. Insulin attenuates the systemic inflammatory response in endotoxemic rats. Endocrinol. 2004;145:4084–93.CrossRef

15.

Dandona P, Aljada A, Mohanty P, Ghanim H, Hamouda W, Assian E, et al. Insulin inhibits intranuclear nuclear factor κB and stimulates IκB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect? J Clin Endocrinol Metab. 2001;86:3257–65.PubMed

16.

Leverence JT, Medhora M, Konduri GG, Sampath V. Lipopolysaccharide-induced cytokine expression in alveolar epithelial cells: role of PKCζ-mediated p47phox phosphorylation. Chemico-Biol Inter. 2011;189:72–81.CrossRef

17.

Dallot E, Méhats C, Oger S, Leroy MJ, Breuiller-Fouché MA. Role for PKCζ in the LPS-induced translocation NF-κB p65 subunit in cultured myometrial cells. Biochimie. 2005;87:513–21.CrossRefPubMed

18.

Li H, Liu B, Huang J, Chen H, Guo X, Yuan Z. Insulin inhibits lipopolysaccharide-induced nitric oxide synthase expression in rat primary astrocytes. Brain Res. 2013;1506:1–11.CrossRefPubMed

19.

Martins JO, Ferracini M, Ravanelli N, Landgraf RG, Jancar S. Insulin suppresses LPS-induced iNOS and COX-2 expression and NF-κB activation in alveolar macrophages. Cell Physiol Biochem. 2008;22:279–86.CrossRefPubMed

20.

Huang XH, Doerner AM, Pan WW, Smith L, Huang S, Papdimor TJ, et al. An atypical protein kinase C (PKCζ) plays a critical role in lipopolysaccharide-activated NF-κB in human peripheral blood monocytes and macrophages. J Immunol. 2009;182:5810–5.CrossRefPubMed

21.

Aye IL, Jansson T, Powell TL. Interleukin-1β inhibits insulin signaling and prevents insulin-stimulated system amino acid transport in primary human trophoblasts. Mol Cell Endocrinol. 2013;381:46–55.PubMedCentralCrossRefPubMed

22.

Gual P, Le Marchand-Brustel Y, Tanti JF. Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie. 2005;87:99–109.CrossRefPubMed

23.

Copps KD, Hancer NJ, Opare-Ado L, Qiu W, Walsh C, White MF. IRS1 serine 307 promotes insulin sensitivity in mice. Cell Metab. 2010;11:84–92.PubMedCentralCrossRefPubMed

24.

Balakrishnan K, Verdile G, Mehta PD, Beilby J, Nolan D, Galvao DA, et al. Plasma Aβ42 correlates positively with increased body fat in healthy individuals. J Alz Dis. 2005;8:269–82.

25.

Biessels G, Kappelle LJ. Increased risk of Alzheimer’s disease in type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology? Biochem Soc Trans. 2005;33:1041–4.CrossRefPubMed

26.

Casserly I, Topol E. Convergence of atherosclerosis and Alzheimer’s disease: inflammation, cholesterol, and misfolded proteins. Lancet. 2004;363:1139–46.CrossRefPubMed

27.

De Felice FG. Alzheimer’s disease and insulin resistance: translating basic science into clinical applications. J Clin Invest. 2013;123:531–9.PubMedCentralCrossRefPubMed

28.

Wang KC, Woung LC, Tsai MT, Liu CC, Su YH, Li CY. Risk of Alzheimer’s disease in relation to diabetes: a population-based cohort study. Neuroepidemiol. 2012;38:237–44.CrossRef

29.

Havrankova J, Roth J, Brownstein M. Insulin receptors are widely distributed in the central nervous system of the rat. Nature. 1978;272:827–9.CrossRefPubMed

30.

Zhao WQ, Alkon DL. Role of insulin and insulin receptor in learning and memory. Mol Cell Endocrinol. 2001;177:125–34.CrossRefPubMed

31.

Clarke DW, Mudd L, Boyd Jr FT. Insulin is released from rat brain neuronal cells in culture. J Neurochem. 1986;47:831–6.CrossRefPubMed

32.

Valenciano AI, Corrochano S, de Pablo F, de la Villa P, de la Rosa EJ. Proinsulin/insulin is synthesized locally and prevents caspase- and cathepsin-mediated cell death in the embryonic mouse retina. J Neurochem. 2006;99:524–36.CrossRefPubMed

33.

Dou JT, Chen M, Dufour F, Alkon DL, Zhao WQ. Insulin receptor signaling in long-term memory consolidation following spatial learning. Learn Mem. 2005;12:646–55.PubMedCentralCrossRefPubMed

34.

Born J, Lange T, Kern W, McGregor GP, Bickel U, Fehm HL. Sniffing neuropeptides: a transnasal approach to the human brain. Nat Neurosci. 2002;5:514–6.CrossRefPubMed

35.

Benedict C, Hallschmid M, Hatke A, Schultes B, Fehm HL, Born J, et al. Intranasal insulin improves memory in humans. Psychoneuroendocrinol. 2004;29:1326–34.CrossRef

36.

Reger MA, Watson GS, Green PS, Wilkinson CW, Baker LD, Cholerton B, et al. Intranasal insulin improves cognition and modulates beta-amyloid in early AD. Neurol. 2008;70:440–8.CrossRef

37.

Adzovic L, Domenici L. Insulin induces phosphorylation of the AMPA receptor subunit GluR1, reversed by ZIP, and overexpression of protein kinase M zeta, reversed by amyloid beta. J Neurochem. 2014;31:582–7.CrossRef

38.

Kamal A, Ramakers GM, Gispen WH, Biessels GJ. Effect of chronic intracerebroventricular insulin administration in rats on the peripheral glucose metabolism and synaptic plasticity of CA1 hippocampal neurons. Brain Res. 2012;1435:99–104.CrossRefPubMed

39.

Marchalant Y, Cerbai F, Brothers H, Wenk GL. Cannabinoid receptor stimulation is anti-inflammatory and improves memory in old rats. Neurobiol Aging. 2008;29:1894–901.PubMedCentralCrossRefPubMed

40.

Marchalant Y, Brothers HM, Norman GJ, Karolina K, DeVries C, Wenk GL. Cannabinoids attenuate the effects of aging upon neuroinflammation and neurogenesis. Neurobiol Dis. 2009;34:300–7.CrossRefPubMed

41.

Hauss-Wegrzyniak B, Dobrzanski P, Stoehr JD, Wenk GL. Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer’s disease. Brain Res. 1998;780:294–303.CrossRefPubMed

42.

Hauss-Wegrzyniak B, Galons JP, Wenk GL. Quantitative volumetric analysis of brain magnetic resonance imaging from rat with chronic neuroinflammation and correlation with histology. Exp Neurol. 2000;165:347–54.CrossRefPubMed

43.

Hauss-Wegrzyniak B, Lynch MA, Vraniak PD, Wenk GL. Chronic brain inflammation results in cell loss in the entorhinal cortex and impaired LTP in perforant path-granule cell synapses. Exp Neurol. 2002;341:336–41.CrossRef

44.

Rosi S, Ramirez-Amaya V, Hauss-Wegrzyniak B, Wenk GL. Chronic brain inflammation leads to a decline in hippocampal NMDA R1 receptors. J Neuroinflam. 2004;1:12–8.CrossRef

45.

Rosi S, Ramirez-Amaya V, Vazdarjanova A, Esperanza E, Larkin P, Fike JR, et al. Accuracy of hippocampal network activity is disrupted by neuroinflammation: rescue by memantine. Brain. 2009;132:2464–86.PubMedCentralCrossRefPubMed

46.

Rosi S, Ramirez-Amaya V, Vazdarjanova A, Worley PF, Barnes CA, Wenk GL. Neuroinflammation alters the hippocampal pattern of behaviorally induced Arc expression. J Neurosci. 2005;25:723–31.CrossRefPubMed

47.

Wenk GL, Hauss-Wegrzyniak B, Willard LB. Pathological and biochemical studies of chronic neuroinflammation may lead to therapies for Alzheimer’s disease. In: Patterson P, Kordon C, Christen Y, editors. Research and perspectives in neurosciences: neuro-immune neurodegenerative and psychiatric disorders and neural injury. Heidelberg: Springer-Verlag; 2000. p. 73–7.

48.

Marchalant Y, Rosi S, Wenk GL. Anti-inflammatory property of the cannabinoid agonist WIN-55212-2 in a rodent model of chronic brain inflammation. Neurosci. 2007;144:1516–22.CrossRef

49.

Figlewicz DP, Bennett J, Evans SB, Kaiyala K, Sipols AJ, Benoit SC. Intraventricular insulin and leptin reverse place preference conditioned with high-fat diet in rats. Behav Neurosci. 2004;118:479–87.CrossRefPubMed

50.

Bardou I, Brothers HM, Kaercher RM, Hopp SC, Wenk GL. Differential effects of duration and age upon the consequences of neuroinflammation in the hippocampus. Neurobiol Aging. 2013;34:2293–301.PubMedCentralCrossRefPubMed

51.

Martins JO, Ferracini M, Ravanelli N, Landgraf RG, Jancar S. Insulin inhibits LPS-induced signaling pathways in alveolar macrophages. Cell Physiol Biochem. 2007;21:297–304.CrossRef

52.

Bamji-Mirza M, Callaghan D, Najem D, Shen S, Hasim MS, Yang Z, et al. Stimulation of insulin signaling and inhibition of JNK-AP1 activation protect cells from amyloid-β-induced signaling dysregulation and inflammatory response. J Alz Dis. 2014;40:105–22.

53.

Brothers HM, Bardou I, Hopp SC, Kaercher RM, Corona AW, Fenn AM, et al. Riluzole partially rescues age-associated, but not LPS-induced, loss of glutamate transporters and spatial memory. J Neuroimm Pharmacol. 2013;8:1098–105.CrossRef

54.

Leitges M, Sanz L, Martin P, Duran A, Braun U, García JF, et al. Targeted disruption of the zeta PKC gene results in the impairment of the NF-κB pathway. Mol Cell. 2001;8:771–80.CrossRefPubMed

55.

Frölich L, Blum–Degen D, Bernstein HG, Englesberger S, Humrich J, Laufer S, et al. Insulin and insulin receptors in the brain in aging and in sporadic Alzheimer’s disease. J Neural Transm. 1998;105:423–38.CrossRefPubMed

56.

Townsend M, Metha T, Selkoe DJ. Soluble A-beta inhibits specific signal transduction cascades common to the insulin receptor pathway. J Biol Chem. 2007;282:33305–12.CrossRefPubMed

Title: Insulin improves memory and reduces chronic neuroinflammation in the hippocampus of young but not aged brains
Authors: Linda Adzovic
Ashley E Lynn
Heather M D’Angelo
Alexis M Crockett
Roxanne M Kaercher
Sarah E Royer
Sarah C Hopp
Gary L Wenk
Publication date: 01-12-2015
Publisher: BioMed Central
Published in: Journal of Neuroinflammation / Issue 1/2015
Electronic ISSN: 1742-2094
DOI: https://doi.org/10.1186/s12974-015-0282-z

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Insulin improves memory and reduces chronic neuroinflammation in the hippocampus of young but not aged brains

Abstract

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2015

Endogenous antibodies contribute to macrophage-mediated demyelination in a mouse model for CMT1B

Prolactin in combination with interferon-β reduces disease severity in an animal model of multiple sclerosis

Erratum to: Insulin improves memory and reduces chronic neuroinflammation in the hippocampus of young but not aged brains

Behavioural and neurobiological consequences of macrophage migration inhibitory factor gene deletion in mice

Erratum to: A role for human brain pericytes in neuroinflammation

Colony-stimulating factor 1 receptor inhibition prevents microglial plaque association and improves cognition in 3xTg-AD mice